Entering text into the input field will update the search result below

New Finance VP at Mersana Therapeutics

  • Mersana Therapeutics (NASDAQ:MRSN) appoints Brian C. DeSchuytner as Senior Vice President of Finance and Product Strategy.
  • David A. Spellman, Chief Financial Officer of the Company will also resign to pursue other opportunities.
  • Mr. DeSchuytner joins Mersana from TESARO, where he was Vice President responsible for the ZEJULA (niraparib) commercialization. He will start at Mersana on July 10.

Recommended For You

More Trending News

About MRSN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MRSN--
Mersana Therapeutics, Inc.